Author:
Majuran Vinayaka Moorthy,Vinayakamoorthy Vidhiya,Svasti-Salee Derek
Reference106 articles.
1. Gomez P, et al. Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated? BJU Int. 2004;94(3):299–302.
2. Han M, et al. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol. 2003;169(2):517–23.
3. Heidenreich A, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol. 2011;59:61–71. Epub 2010 Oct 28.
4. Even-Sapir E, et al. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. J Nucl Med. 2006;47(2):287–97.
5. Choueiri MB, et al. The central role of osteoblasts in the metastasis of prostate cancer. Cancer Metastasis Rev. 2006;25(4):601–9.